Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session

See Release

All News

Archives

Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board John McDermott to Continue as Chief Executive Officer

Positive Three-Year Results from the Ovation® European Post Market Registry Presented at 2017 LINC Symposium

Endologix Announces Reinstatement of CE Mark for AFX® and AFX®2 Endovascular AAA System

Endologix Resumes Shipments of All Sizes of AFX®2 Endovascular AAA Systems Appoints Laura Nagel as Vice President, Global Quality

Endologix Provides Physicians with Updated Information about the AFX® Endovascular AAA System